Add BrightSurf on Google Email

Pelvic lymphadenectomy does not improve survival in early stage endometrial cancer

A randomized trial found that systematic pelvic lymphadenectomy did not improve disease-free or overall survival in women with stage I endometrial cancer. Lymphadenectomy was associated with improved surgical staging and detection of disease spread to pelvic lymph nodes, but no therapeutic benefit.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 25, 2008

Tracking and feedback registry may reduce racial disparities in breast cancer care

A tracking and feedback system reduced racial disparities in adjuvant therapy among women with early-stage breast cancer, increasing consultations with medical oncologists by 14 percentage points. The study found a decrease in underuse of adjuvant treatment, particularly among black and Hispanic women.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateNov 25, 2008

Sexual intimacy and breast cancer survivors: New research

A new study by Indiana University found that young female breast cancer survivors experience significant problems related to sexual arousal, desire, and orgasm. Many reported vaginal dryness, genital pain, premature menopause, fatigue, and fertility issues, highlighting the need for research on strategies to address these challenges.

SourceIndiana University·JournalCancer Nursing·DateNov 10, 2008

JCI online early table of contents: Nov. 6, 2008

Researchers have developed approaches to visualize eosinophils in real-time, which may help diagnose asthma and assess treatment efficacy. Additionally, genetic defects underlying two kidney conditions and a type of liver cancer have been identified, suggesting potential therapeutic targets for these diseases.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 6, 2008

Therapy may block expansion of breast cancer cells

A new study reveals that therapy targeting cyclin D1 can block the expansion of breast cancer cells, which are involved in therapy resistance and tumor recurrence. The findings provide a potential new treatment approach for targeted therapies at cancer stem cells in humans.

SourceWiley·JournalClinical and Translational Science·DateNov 5, 2008

Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening

A non-invasive oral rinse screening method has shown promise in detecting high-risk human papillomavirus (HPV) infections in patients with head and neck cancers. The study found that oral HPV16 infections were significantly more common among patients with HPV-positive tumors, indicating a potential link between the two.

SourceAmerican Association for Cancer Research·JournalClinical Cancer Research·DateOct 31, 2008

Also in the Oct. 28 JNCI

Research found skewed X inactivation in women with BRCA1 gene mutations, associated with a later onset of breast or ovarian cancer. The Impact of Cancer scale was also refined and validated, providing a tool to measure long-term psychosocial impact on cancer survivors.

SourceJournal of the National Cancer Institute·JournalJNCI Journal of the National Cancer Institute·DateOct 28, 2008

Treatment window expanded

A new study published in the New England Journal of Medicine found that patients can still benefit from dissolving blood clots in the brain up to 4.5 hours after a stroke. The study, known as ECASS 3, involved 826 patients who received either the thrombolytic drug alteplase or a placebo, with better response rates and no increased mort...

SourceHeidelberg University Hospital·JournalNew England Journal of Medicine·DateSep 30, 2008